STRENGTH IN NUMBERS

Strength in Numbers dedicated to my late mother Kay

Prostate cancer drug ruling a ‘fiasco’, says charity

Abiraterone is already given to patients at the end-of-life after chemotherapy as it gives patients an extra few months.
But the National Institute for Health and Care Excellence said it was not cost-effective to offer it earlier.
It said while the drug improved quality of life, it was unclear whether it had the same impact on life expectancy.
This was due to problems with the research data, NICE said, claiming the trial was finished early – something disputed by the drug’s makers Janssen.
‘Vital opportunity’
Instead, patients will have to rely on their doctors applying to the Cancer Drugs Fund, a special pot set aside for cancer drugs not routinely available on the NHS.
Some 3,000 patients have done this in the last year, but that fund is due to end in 2016.
Owen Sharp, chief executive of Prostate Cancer UK, the largest men’s health charity, said the whole process was “a fiasco”.
Jump media playerMedia player helpOut of media player. Press enter to return or tab to continue.
Cancer patient Mike Sawkins: “I’m privileged to be on this expensive drug”
He criticised NICE’s inflexibility and the drug company’s results-gathering process, saying: “This decision is a kick in the teeth for men with advanced prostate cancer.

Click on the link to see video and read more
http://www.bbc.co.uk/news/health-28785250

_76949561_m8650341-prostate_cancer_ce

Filed under: Uncategorized, , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Pages

%d bloggers like this: